自膨式金属支架在恶性远端胆道狭窄治疗中优于塑料支架
本研究为队列研究,比较塑料支架与自膨式金属支架治疗恶性胆道狭窄的疗效与不良结局。结果显示,在远端狭窄中,金属支架临床成功率更高(94.1% vs 87.4%,P<0.001)、非计划再干预率更低(17.1% vs 27.4%,P<0.001),且胆管炎发生率更低;在肝门部狭窄中两者临床成功率与再干预率相当,但金属支架通畅时间更长。结论推荐金属支架作为恶性远端胆道狭窄的一线内镜治疗选择。
要点
- 恶性远端胆道狭窄:金属支架临床成功率高于塑料支架。
- 金属支架非计划再干预率更低,通畅时间更长。
- 肝门部狭窄两者疗效相当,金属支架耐久性更优。
核心结论
- 对于恶性远端胆道狭窄,自膨式金属支架应作为一线内镜治疗选择。
- 对于恶性肝门部狭窄,自膨式金属支架在某些情况下是塑料支架的有吸引力的替代方案。
研究设计与样本
- 队列研究,纳入2012至2019年因恶性胆道狭窄接受ERCP支架置入的连续患者。
- 塑料支架组1139例,自膨式金属支架组1008例。
主要发现
- 远端狭窄中,金属支架临床成功率显著高于塑料支架(94.1% vs 87.4%,P<0.001)。
- 远端狭窄中,金属支架非计划再干预率显著低于塑料支架(17.1% vs 27.4%,P<0.001)。
- 肝门部狭窄中,两组临床成功率与非计划再干预率相当。
- 无论狭窄位置,金属支架的通畅时间和至非计划再干预时间均显著长于塑料支架。
- 远端狭窄中,塑料支架胆管炎发生率显著高于金属支架(6.9% vs 2.4%,P<0.001),但胰腺炎发生率更低(3.6% vs 6%,P=0.021)。
临床怎么用
- 恶性远端胆道狭窄优先选择自膨式金属支架以提升临床成功率并减少再干预。
- 肝门部狭窄可考虑自膨式金属支架作为塑料支架的替代,以获取更长的通畅时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Treatment of malignant biliary strictures with endoscopic retrograde cholangiopancreatography (ERCP) guided stent placement is highly effective. Our objective was to compare the efficacy and adverse outcomes between plastic stents (PS) and self-expandable metallic stents (SEMS). METHODS: A cohort study was performed of all consecutive patients who underwent ERCP with stent placement for the management of malignant biliary stricture. Comparisons on clinical success, patency duration, stent dysfunction, unplanned reintervention and adverse outcomes were performed. Univariate and multivariable analyses were performed to identify factors associated with clinical success, need for reintervention, and stent dysfunction. RESULTS: From 2012 to 2019, 1139 patients underwent ERCP with PS placement while 1008 patients received SEMS for the management of malignant biliary stricture. In distal strictures, SEMS reported a significantly higher rate of clinical success compared with PS (94.1% vs 87.4%, P < 0.001) and a lower rate of unplanned reintervention (17.1% vs 27.4%, P < 0.001). In hilar strictures, the rates of clinical success and unplanned intervention were comparable. The patency duration and time to unplanned reintervention were significantly longer with SEMS than PS, irrespective of stricture location. In distal stricture, PS was associated with a significantly higher rate of cholangitis than SEMS (6.9% vs 2.4%; P < .001) but a lower rate of pancreatitis (3.6% vs 6%; P = 0.021). CONCLUSION: Given superior efficacy, durability and lower rates of cholangitis, SEMS should be offered as the first line endoscopic treatment option for malignant distal biliary stricture. For malignant hilar stricture, SEMS is an attractive alternative to PS in some cases by offering a comparable efficacy with a superior durability.
引用
- Jang S, Stevens T, Parsi MA, et al. Superiority of Self-Expandable Metallic Stents Over Plastic Stents in Treatment of Malignant Distal Biliary Strictures. Clin Gastroenterol Hepatol. 2020. PMID: 33346140. doi:10.1016/j.cgh.2020.12.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。